The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department

INTRODUCTION: Droperidol carries a boxed warning from the United States Food and Drug Administration for QT prolongation and torsades des pointes (TdP). After a six-year hiatus, droperidol again became widely available in the US in early 2019. With its return, clinicians must again make decisions re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, Jon B., Lee, Samantha C., Martel, Marc L., Smith, Stephen W., Biros, Michelle H., Miner, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2020
Materias:
Patient Safety
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390553/
https://www.ncbi.nlm.nih.gov/pubmed/32726229
http://dx.doi.org/10.5811/westjem.2020.4.47036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390553/
https://www.ncbi.nlm.nih.gov/pubmed/32726229
http://dx.doi.org/10.5811/westjem.2020.4.47036

Ejemplares similares